Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
Genes Chromosomes Cancer. 2020 Jun;59(6):348-356. doi: 10.1002/gcc.22835. Epub 2020 Feb 7.
Myoepithelial tumors (MET) represent a clinicopathologically heterogeneous group of tumors, ranging from benign to highly aggressive lesions. Although MET arising in soft tissue, bone, or viscera share morphologic and immunophenotypic overlap with their salivary gland and cutaneous counterparts, there is still controversy regarding their genetic relationship. Half of MET of soft tissue and bone harbor EWSR1 or FUS related fusions, while MET arising in the salivary gland and skin often show PLAG1 and HMGA2 gene rearrangements. Regardless of the site of origin, the gold standard in diagnosing a MET relies on demonstrating its "myoepithelial immunophenotype" of positivity for EMA/CK and S100 protein or GFAP. However, the morphologic spectrum of MET in soft tissue and bone is quite broad and the above immunoprofile is nonspecific, being shared by other pathogenetically unrelated neoplasms. Moreover, rare MET lack a diagnostic immunoprofile but shows instead the characteristic gene fusions. In this study, we analyzed a large cohort of 66 MET with EWSR1 and FUS gene rearrangements spanning various clinical presentations, to better define their morphologic spectrum and establish relevant pathologic-molecular correlations. Genetic analysis was carried out by FISH for EWSR1/FUS rearrangements and potential partners, and/or by targeted RNA sequencing. Then, 82% showed EWSR1 rearrangement, while 18% had FUS abnormalities. EWSR1-POU5F1 occurred with predilection in malignant MET in children and young adults and these tumors had nested epithelioid morphology and clear cytoplasm. In contrast, EWSR1/FUS-PBX1/3 fusions were associated with benign and sclerotic spindle cell morphology. Tumors with EWSR1-KLF17 showed chordoma-like morphology. Our results demonstrate striking morphologic-molecular correlations in MET of bone, soft tissue and viscera, which might have implications in their clinical behavior.
肌上皮肿瘤(MET)是一组临床病理表现高度异质性的肿瘤,包括从良性到高度侵袭性病变。虽然发生于软组织、骨或内脏的 MET 与唾液腺和皮肤来源的肿瘤在形态学和免疫表型上具有重叠,但它们在遗传学上的关系仍存在争议。一半的软组织和骨源性 MET 存在 EWSR1 或 FUS 相关融合,而发生于唾液腺和皮肤的 MET 则常表现为 PLAG1 和 HMGA2 基因重排。无论起源部位如何,诊断 MET 的金标准依赖于其“肌上皮免疫表型”,即 EMA/CK 和 S100 蛋白或 GFAP 阳性。然而,软组织和骨源性 MET 的形态学谱非常广泛,上述免疫表型不具有特异性,也存在于其他发病机制上无关的肿瘤中。此外,罕见的 MET 缺乏诊断性免疫表型,但表现出特征性的基因融合。在这项研究中,我们分析了一组跨越多种临床表现的 66 例存在 EWSR1 和 FUS 基因重排的 MET,以更好地定义其形态学谱并建立相关的病理-分子相关性。通过 FISH 进行 EWSR1/FUS 重排及其潜在伙伴的检测,或通过靶向 RNA 测序进行检测。然后,82%的病例显示 EWSR1 重排,而 18%的病例存在 FUS 异常。EWSR1-POU5F1 易发生于儿童和年轻成人的恶性 MET 中,这些肿瘤具有巢状上皮样形态和透明细胞质。相比之下,EWSR1/FUS-PBX1/3 融合与良性和硬化性梭形细胞形态相关。具有 EWSR1-KLF17 重排的肿瘤具有脊索瘤样形态。我们的研究结果表明,骨、软组织和内脏的 MET 存在显著的形态-分子相关性,这可能对其临床行为具有重要意义。